Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GAES is a hearing healthcare brand focused on audiology services and hearing solutions, primarily in Spain and other Spanish-speaking markets. The business provides hearing tests, hearing aids, cochlear and bone-conduction/osteointegrated implant support, hearing protection products, and related aftercare through a large network of hearing centers. Founded in Barcelona in 1949, GAES built a leading retail and distribution position in hearing correction before being acquired by Amplifon in 2018. Today it operates as "GAES, una marca Amplifon," serving consumers through a commercial, patient-service-oriented model rather than a drug-development biotech pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GAES.